Hirudin-based anticoagulant strategies for patients with suspected heparin-induced thrombocytopenia undergoing percutaneous coronary interventions and bypass grafting

Journal of Thrombosis and Thrombolysis

Volumn 10, Issue SUPPL. 1, 2000, Pages

  Becker, R C ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Heparin induced thrombocytomis; Hirudin; Revascularization

Indexed keywords

CREATININE; HEPARIN; LEPIRUDIN; RECOMBINANT HIRUDIN;

ANTICOAGULANT THERAPY; CLINICAL MEDICINE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DEEP VEIN THROMBOSIS; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; PATIENT MONITORING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ANTITHROMBINS; BLOOD COAGULATION TESTS; CORONARY ARTERY BYPASS; HEPARIN; HIRUDIN THERAPY; HIRUDINS; HUMANS; RECOMBINANT PROTEINS; RISK; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0034498647     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Über die einwirkung eines sekretes des officinellen blutegels auf die gerinnbarkeit des blutes
2. Die Isolierung und chemische charakterisierung des hirudins
3. Hirudin as an inhibitor of thrombin
4. Analysis of the secondary structure of hirudin and the mechanism of its interaction with thrombin
5. Heterologous gene expression in Saccharomyces cerevisiae
6. Pharmacology of r-hirudin in renal impairment
7. Recombinant hirudin in patients with chronic, stable coronary artery disease: Safety, half-life and effect on coagulation parameters
8. Biologic effects of recombinant hirudin (CGP39393) in human volunteers
9. Kinetics of the inhibition of thrombin by hirudin
10. Monitoring of recombinant hirudin: Assessment of a plasma-based ecarin clotting time assay
11. Hirudin, heparin, and placebo during deep arterial injury in the pig: The in vivo role of thrombin in platelet-mediated thrombosis
12. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs: Heparin versus recombinant hirudin, a specific thrombin inhibitor
13. Platelet and fibrin deposition in coronary stents in minipigs: Effect of hirudin versus heparin
14. Recombinant hirudin for unstable angina pectoris: A multicenter, randomized angiographic trial
15. A pilot trial of recombinant desulfatohirudin compared to heparin in conjunction with tissue plasminogen activator and aspirin for acute myocardial infarction (TIMI 5 Trial)
16. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty
17. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty
18. Hirudin in acute myocardial infarction: Thrombolysis and thrombin Inhibition in Myocardial Infarction (TIMI) 9B Trial
19. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes:1 the Global Use of Strategies to Open acute coronary syndromes occluded coronary arteries (GUSTO) IIb Investigators
20. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina
21. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris
22. A new approach in monitoring recombinant hirudin during cardiopulmonary bypass
23. Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia Type II emplying recombinant hirudin
24. Monitoring of r-hirudin anti-coagulatin during cardiopulmonary bypass-assessment of the whole blood ecarin clotting time
25. Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: Successful aortic valve replacement in man
26. Heparin induced experiences in 12 heart surgery patients
27. A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgery
28. Pharmacokinetics of recombinant hirudin in hemodialysed end-stage renal failure patients
29. Prevention of deep-vein thrombosis after total hip replacement: Direct thrombin inhibition with recombinant hirudin, CGP 39393